Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial

Silymarin is proclaimed to be a blend of flavonolignans or phytochemicals. An era of new generation of direct-acting antivirals (DAAs) has commenced to have facet effect in swaying of the hepatitis C virus (HCV). Nonetheless, this therapy has serious side effects that jeopardize its efficacy. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Sarfraz, Ullah, Najeeb, Parveen, Sadia, Javed, Ifra, Jalil, Nur Asyilla Che, Murtey, Mogana Das, Sheikh, Irfan Shahzad, Khan, Shahroz, Ojha, Suvash Chandra, Chen, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828344/
https://www.ncbi.nlm.nih.gov/pubmed/35154575
http://dx.doi.org/10.1155/2022/9199190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828344/
https://www.ncbi.nlm.nih.gov/pubmed/35154575
http://dx.doi.org/10.1155/2022/9199190

Ejemplares similares